83
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Pain Severity and Interference in Different Parkinson’s Disease Cognitive Phenotypes

ORCID Icon, , &
Pages 3493-3497 | Published online: 29 Dec 2020

References

  • Aarsland D, Bronnick K, Williams-Gray C, et al. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology. 2010;75:1062–1069.
  • Goldman JG, Weis H, Stebbins G, Bernard B, Goetz CG. Clinical differences among mild cognitive impairment subtypes in Parkinson’s disease. Mov Disord. 2012;27:1129–1136.
  • Goldman JG, Aggarwal NT, Schroeder CD. Mild cognitive impairment: an update in Parkinson’s disease and lessons learned from Alzheimer’s disease. Neurodegener Dis Manag. 2015;5:425–443.
  • Tanner JJ, Mareci TH, Okun MS, Bowers D, Libon DJ, Price CC. Temporal lobe and frontal-subcortical dissociations in non-demented Parkinson’s disease with verbal memory impairment. PLoS One. 2015;10:e0133792.
  • Price CC, Tanner J, Nguyen PT, et al. Gray and white matter contributions to cognitive frontostriatal deficits in non-demented Parkinson’s disease. PLoS One. 2016;11:e0147332.
  • Broen MP, Braaksma MM, Patijn J, Weber WE. Prevalence of pain in Parkinson’s disease: a systematic review using the modified QUADAS tool. Mov Disord. 2012;27:480–484.
  • Beiske AG, Loge JH, Ronningen A, Svensson E. Pain in Parkinson’s disease: prevalence and characteristics. Pain. 2009;141:173–177.
  • Defazio G, Berardelli A, Fabbrini G, et al. Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol. 2008;65:1191–1194.
  • Negre-Pages L, Regragui W, Bouhassira D, Grandjean H, Rascol O. Chronic pain in Parkinson’s disease: the cross-sectional French DoPaMiP survey. Mov Disord. 2008;23:1361–1369.
  • Young Blood MR, Ferro MM, Munhoz RP, Teive HA, Camargo CH. (2016) Classification and characteristics of pain associated with Parkinson’s disease. Parkinsons Dis. 2016;6067132.
  • Berryman C, Stanton TR, Bowering KJ. Do people with chronic pain have impaired executive function? A meta-analytical review. Clin Psychol Rev. 2014;34:563–579.
  • Oosterman JM, Dijkerman HC, Kessels RP, Scherder EJ. A unique association between cognitive inhibition and pain sensitivity in healthy participants. Eur.J.Pain. 2010;14:1046–1050.
  • Bjekic J, Zivanovic M, Puric D, Oosterman JM, Filipovic SR. Pain and executive functions: a unique relationship between Stroop task and experimentally induced pain. Psychol Res. 2017;1:15.
  • Tracey I, Mantyh PW. The cerebral signature for pain perception and its modulation. Neuron. 2007;55:377–391.
  • Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci. 1986;9:357–381.
  • Crowley SJ, Banan G, Amin M. Statistically defined Parkinson’s Disease executive and memory cognitive phenotypes: demographic, behavioral, and structural neuroimaging comparisons. J Parkinson’s Dis. 2015;2:1254
  • Crowley SJ, Hizel L, Tanner JJ, Cruz-Almeida Y, Price CC. In International Neuropsychological Society. Washington, DC; 2018.
  • Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study. Neurology. 1992;42:1142–1146.
  • Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427–442.
  • Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF. A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord. 2008;23:183–189.
  • den Brok MG, van Dalen JW, van Gool WA. Apathy in Parkinson’s disease: a systematic review and meta-analysis. Mov Disord. 2015;30:759–769.
  • Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson’s disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology. 1990;40:1529–1534.
  • Cleeland CS. Measurement of pain by subjective report. In: Cr C, Jd L, editors. Advances in Pain Research and Therapy Vol. 12: Issues in Pain Management. New York: Raven Press; 1989:391–403.
  • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
  • Sheikh JA, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol. 1986.
  • Tomlinson CL, Stowe R, Patel S, Rick C, Gray R. Clarke CE Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord. 2017;25:2649–2653.
  • Carnahan RM, Lund BC, Perry PJ, Pollock BG, Culp KR. The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol. 2006;46:1481–1486.
  • Wechsler D. WAIS-III Administration and Scoring Manual (3rd Ed). San Antonio, TX: The Psychological Corporation; 1997.
  • Jensen AR, Rohwer WD. The Stroop color-word test: a review. Acta Psychol (Amst). 1966;25:36–93.
  • Spreen O, Strauss E. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York: Oxford University Press; 1991.
  • Benedict RHB, Schretlen D, Groninger L, Brandt J. Hopkins Verbal Learning Test – revised: normative Data and Analysis of Inter-Form and Test-Retest Reliability. Clin Neuropsychol. 1998;12:43–55.
  • Wechsler D. WAIS-III: Wechsler Adult Intelligence Scale. Psychological Corporation; 1997.
  • Zis P, Daskalaki A, Bountouni I, Sykioti P, Varrassi G, Paladini A. Depression and chronic pain in the elderly: links and management challenges. Clin Interv Aging. 2017;12:709–720.
  • Rock PL, Roiser JP, Riedel WJ, Blackwell AD. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med. 2014;44:2029–2040.
  • Okada A, Nakamura T, Suzuki J, et al. Impaired pain processing correlates with cognitive impairment in Parkinson’s disease. Intern Med. 2016;55:3113–3118.
  • Engels G, Weeda WD, Vlaar AM, Weinstein HC, Scherder EJ. Clinical pain and neuropsychological functioning in Parkinson’s disease: are they related? Parkinsons Dis. 2016;(2016):8675930.
  • Hanganu A, Bedetti C, Degroot C, et al. Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson’s disease longitudinally. Brain. 2014;137:1120–1129.
  • Tinaz S, Courtney MG, Stern CE. Focal cortical and subcortical atrophy in early Parkinson’s disease. Mov Disord. 2011;26:436–441.
  • Aschermann Z, Nagy F, Perlaki G, et al. ‘Wind-up’ in Parkinson’s disease: a functional magnetic resonance imaging study. Eur J Pain. 2015;19:1288–1297.
  • Forkmann K, Grashorn W, Schmidt K, Frundt O, Buhmann C, Bingel U. Altered neural responses to heat pain in drug-naive patients with Parkinson disease. Pain. 2017;158:1408–1416.
  • Polli A, Weis L, Biundo R, et al. Anatomical and functional correlates of persistent pain in Parkinson’s disease. Mov Disord. 2016;31:1854–1864.
  • Levesque J, Eugene F, Joanette Y, et al. Neural circuitry underlying voluntary suppression of sadness. Biol Psychiatry. 2003;53:502–510.
  • Ohira H, Nomura M, Ichikawa N, et al. Association of neural and physiological responses during voluntary emotion suppression. Neuroimage. 2006;29:721–733.
  • Apkarian AV, Bushnell MC, Treede RD, Zubieta JK. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain. 2005;9:463–484.
  • Dworkin RH, Turk DC, Wyrwich KW. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008;9:105–121.